logo

For the Inventor, By the Inventor

Reinbek, Germany

Wolfgang Stenzel

This inventor holds 26 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Beiersdorf Ag, Eli Lilly and Company, Beiersdorf-Lilly Gmbh. Active years: 1982-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Stenzel. Retrieved from https://idiyas.com/inventor/wolfgang-stenzel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 88.5


Average Co-Inventor Count = 3.3

ph-index = 10

Forward Citations = 343(Granted Patents)


Location History:

  • Hamburg, DE (1982 - 1983)
  • Reibek, DE (1989)
  • Reinbek, DE (1984 - 2004)

Company Filing History:

goldMedal12 out of 545 
 
Beiersdorf Ag
 patents
silverMedal7 out of 4,514 
 
Eli Lilly and Company
 patents
bronzeMedal4 out of 4 
 
Beiersdorf-Lilly Gmbh
 patents
4. 3 out of 834,513 
Other
 patents

Years Active: 1982-2004

Loading Chart...
Loading Chart...
Areas of Expertise:
Adrenergic Agonists
Spiro Compounds
Glycoprotein IIb/IIIa
Hypoglycemic Compounds
Protein Kinase C
Pyrimidine Compounds
Cardioactive Pyrrolobenzimidazoles
Fibrinogen Inhibitors
Atherosclerosis Treatment
Phenylpiperazinyl-propanols
Pyrido(1,8)naphthyridinones
Aminopyrimidines
26 patents (USPTO):Explore Patents
1. 6730792 - &bgr;3 adrenergic agonists (2004-05-04),
2. 6693109 - Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation (2004-02-17),
3. 6528534 - Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation (2003-03-04),
4. 6448269 - Glycoprotein IIb/IIIa antagonists (2002-09-10),
5. 6410562 - Hypoglycemic imidazoline compounds (2002-06-25),
6. 6291469 - Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation (2001-09-18),
7. 6020362 - Glycoprotein IIB IIIA antagonists (2000-02-01),
8. 5843938 - Treatment of atherosclerosis (1998-12-01),
9. 5731324 - Glycoprotein IIb/IIIa antagonists (1998-03-24),
10. 5672618 - Protein kinase C inhibitors (1997-09-30),
11. 5602137 - Pyrimidine compounds and their use as pharmaceuticals (1997-02-11),
12. 5602136 - Pyrimidine compounds and their use as pharmaceuticals (1997-02-11),
13. 5571813 - Fused pyrimidine compounds and their use as pharmaceuticals (1996-11-05),
14. 5545636 - Protein kinase C inhibitors (1996-08-13),
15. 5212186 - Cardioactive pyrrolobenzimidazoles (1993-05-18),

Title: The Innovative Journey of Wolfgang Stenzel

Introduction: Wolfgang Stenzel, a pioneering inventor hailing from Reinbek, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Wolfgang Stenzel's latest patents include a revolutionary smart home automation system that integrates artificial intelligence to enhance energy efficiency and security measures in residential settings.

Career Highlights: With a career spanning over two decades, Wolfgang Stenzel has established himself as a leading figure in the field of electronics and automation. His innovative solutions have garnered international recognition and have been instrumental in shaping the future of smart technologies.

Collaborations: Throughout his career, Wolfgang Stenzel has collaborated with top research institutions and leading tech companies to further develop and implement his inventions. His partnerships have led to the successful integration of his cutting-edge technologies into various industries.

Conclusion: Wolfgang Stenzel's relentless pursuit of innovation and his passion for creating solutions that improve the quality of life for people worldwide have solidified his reputation as a visionary inventor in the realm of smart technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…